Orsini Now Distributing CASGEVY® (Exagamglogene Autotemcel), A Gene-Editing Therapy
Orsini has been chosen by Vertex Pharmaceuticals Incorporated to dispense gene-editing therapy CASGEVY® (exagamglogene autotemcel). CASGEVY is a CRISPR/Cas9 gene-edited cell therapy indicated for the ...
Gilead, Vertex initiated as new big biotech buys at Citi
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
STAT10h
Vertex’s upcoming sciatica trial readout is a high-stakes moment in its quest to quell pain
VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.
STAT5h
Pharmalittle: We’re reading about a Merck deal, GSK cancer drug data, and more
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
MarketWatch23h
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
FiercePharma8h
Otsuka, ICU Medical form joint venture to boost IV solution supply in North America
Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...
Dallas Innovates21h
Patented: Verily Life Sciences’ Eye-Mountable Therapeutic Devices and More North Texas Inventive Activity
Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...
Indiatimes23h
Mankind Pharma Share Price
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,01,449.11 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...